0000937556-17-000220.txt : 20171109
0000937556-17-000220.hdr.sgml : 20171109
20171109200710
ACCESSION NUMBER: 0000937556-17-000220
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171108
FILED AS OF DATE: 20171109
DATE AS OF CHANGE: 20171109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee Yongsam
CENTRAL INDEX KEY: 0001403400
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33642
FILM NUMBER: 171192501
MAIL ADDRESS:
STREET 1: C/O MASIMO CORPORATION
STREET 2: 40 PARKER
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MASIMO CORP
CENTRAL INDEX KEY: 0000937556
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 330368882
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 52 DISCOVERY
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-297-7000
MAIL ADDRESS:
STREET 1: 52 DISCOVERY
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
wf-form4_151027601634098.xml
FORM 4
X0306
4
2017-11-08
0
0000937556
MASIMO CORP
MASI
0001403400
Lee Yongsam
C/O MASIMO CORPORATION
52 DISCOVERY
IRVINE
CA
92618
0
1
0
0
EVP & CIO
Common Stock
2017-11-08
4
M
0
5000
30.79
A
74000
D
Common Stock
2017-11-08
4
S
0
5000
89.5946
D
69000
D
Common Stock
2017-11-08
4
M
0
876
27.25
A
69876
D
Common Stock
2017-11-08
4
S
0
876
89.5946
D
69000
D
Common Stock
2017-11-09
4
M
0
8100
27.25
A
77100
D
Common Stock
2017-11-09
4
S
0
8100
89.3112
D
69000
D
Non-Qualified Stock Option (Right to Buy)
30.79
2017-11-08
4
M
0
5000
30.79
D
2009-02-07
2018-02-07
Common Stock
5000.0
0
D
Non-Qualified Stock Option (Right to Buy)
27.25
2017-11-08
4
M
0
876
27.25
D
2011-02-11
2020-02-11
Common Stock
876.0
29124
D
Non-Qualified Stock Option (Right to Buy)
27.25
2017-11-09
4
M
0
8100
27.25
D
2011-02-11
2020-02-11
Common Stock
8100.0
21024
D
The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of August 21, 2017, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $89.00 per share to a high of $90.105 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $89.00 per share to a high of $89.80 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option was granted on February 7, 2008 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
This option was granted on February 11, 2010 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
/s/ David J. Van Ramshorst, Attorney-In-Fact
2017-11-09